Skip to Main Content

Paper Details

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome.
EBioMedicine
5
2022
Author NameAffiliation
Bonaventura ClotetAIDS Research Institute, Institute for Health Science Research Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Hospital Universitari Germans Trias i Pujol, University of Vic - Central University of Catalonia (UVic - UCC)
Roger ParedesAIDS Research Institute, Institute for Health Science Research Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Hospital Universitari Germans Trias i Pujol, University of Vic - Central University of Catalonia (UVic - UCC)
  • 1 - 2

Datasets

Release 1.2